(NYSE: BAX) Baxter International's forecast annual revenue growth rate of 3.82% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.76%.
Baxter International's revenue in 2025 is $10,887,000,000.On average, 7 Wall Street analysts forecast BAX's revenue for 2025 to be $5,817,544,356,048, with the lowest BAX revenue forecast at $5,779,213,329,887, and the highest BAX revenue forecast at $5,862,984,411,315. On average, 7 Wall Street analysts forecast BAX's revenue for 2026 to be $6,033,005,823,033, with the lowest BAX revenue forecast at $5,965,580,218,250, and the highest BAX revenue forecast at $6,090,518,541,338.
In 2027, BAX is forecast to generate $6,231,391,444,223 in revenue, with the lowest revenue forecast at $6,150,134,537,888 and the highest revenue forecast at $6,286,208,165,579.